Target intelligence / Profile preview

Factor inhibiting hypoxia-inducible factor 1 (FIH-1)

Target
FIH-1
Molecular classification
Enzyme, Oxygen sensor, 2-oxoglutarate–dependent dioxygenase
01

Overview

Factor inhibiting hypoxia-inducible factor 1 (FIH-1) is an asparaginyl hydroxylase enzyme that regulates the activity of hypoxia-inducible factor-1α (HIF-1α), a master transcription factor of the hypoxic response. FIH-1 hydroxylates HIF-1α at Asn-803 in the C-terminal transactivation domain under normoxic conditions, which prevents HIF-1α from recruiting transcriptional coactivators like p300/CBP, thus blocking hypoxia-responsive gene expression in the presence of oxygen[1][3][5][6]. FIH-1 is a non-heme Fe(II)/2-oxoglutarate–dependent dioxygenase and serves as a direct cellular oxygen sensor[1][3][6]. Modulating FIH-1 activity represents a potential strategy for treating ischemic disease and cancer by influencing cellular adaptation to hypoxia[5].

Other names
Factor-inhibiting HIF-1FIHHIF1NHIF asparaginyl hydroxylase
02

Mechanism of action

Inhibition of asparaginyl hydroxylase activity increases HIF transcriptional activation by blocking HIF-1α CTAD hydroxylation, allowing interaction with coactivators and expression of hypoxia response genes[1][3][5][6].

03

Biological functions

Regulation of hypoxia-inducible factor (HIF) signalingOxygen sensingPost-translational modification (asparaginyl hydroxylation)Inhibition of transcriptional activation
04

Disease associations

CancerIschemiaInflammationCardiovascular disease
05

Safety considerations

Systemic HIF activation may lead to pathological angiogenesis, erythrocytosis, and may support tumor progression if not tightly regulated[5].
06

Interacting drugs

No marketed drugs specifically targeting FIH-1 as of current evidence, but various 2-oxoglutarate analog inhibitors and pan-hydroxylase inhibitors (investigational compounds targeting HIF pathway) are described as capable of modulating FIH-1[3].
07

Biomarkers

Hydroxylation status of HIF-1α (Asn-803)HIF target gene expression signature (e.g., VEGF, EPO upregulation)

Beyond the preview

Go deeper on Factor inhibiting hypoxia-inducible factor 1 (FIH-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Factor inhibiting hypoxia-inducible factor 1 (FIH-1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call